Evaxion A (EVAX) Cash from Financing Activities (2020 - 2022)
Evaxion A (EVAX) posted Cash from Financing Activities of -$300000.0 for Q2 2022, down 103.88% on a QoQ basis from $7.7 million in Q1 2022, and down 101.19% year-over-year from $25.2 million in Q2 2021.
Evaxion A (EVAX) Cash from Financing Activities (2020 - 2022) Analysis & Trends
Evaxion A's Cash from Financing Activities history runs 3 years deep, the most recent figure standing at -$300000.0 for Q2 2022.
- Quarterly Cash from Financing Activities fell 101.19% year-over-year to -$300000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $57.8 million (up 1.64% YoY) and the FY2025 annual result came in at $22.4 million, up 70.69% from the prior year.
- Cash from Financing Activities was -$300000.0 for Q2 2022 at Evaxion A, down from $7.7 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $25.3 million in Q1 2021 and bottomed at -$300000.0 in Q2 2022.
- A 3-year average of $11.2 million and a median of $7.1 million in 2020 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2021 — Cash from Financing Activities jumped 140388.89% — and 2022, when it tumbled 101.19%.
- Evaxion A's Cash from Financing Activities stood at $6.4 million in 2020, then surged by 290.38% to $25.2 million in 2021, then tumbled by 101.19% to -$300000.0 in 2022.
- Business Quant data shows EVAX's Cash from Financing Activities at -$300000.0 in Q2 2022, $7.7 million in Q1 2022, and $25.2 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 68.63 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 9,311.16 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 238.74 Mn |
| 10 | Evaxion A | 25.44 Mn | 25.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -300,000.00 |
| Jun 30, 2022 | -300,000.00 |
| Mar 31, 2022 | 7.74 Mn |
| Mar 31, 2022 | 7.74 Mn |
| Sep 30, 2021 | 25.15 Mn |
| Sep 30, 2021 | 25.15 Mn |
| Jun 30, 2021 | 25.22 Mn |
| Jun 30, 2021 | 25.22 Mn |
| Mar 31, 2021 | 25.25 Mn |
| Mar 31, 2021 | 25.25 Mn |
| Sep 30, 2020 | 6.44 Mn |
| Sep 30, 2020 | 6.44 Mn |
| Jun 30, 2020 | -36,000.00 |
| Jun 30, 2020 | -36,000.00 |
| Mar 31, 2020 | -18,000.00 |
| Mar 31, 2020 | -18,000.00 |